If you have been reading about G protein-coupled receptor and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2026-05-22. Numbers and descriptions here follow the published literature rather than marketing material.
Compared with the related compound melanotan II, PT-141 shows markedly weaker activation of receptors tied to pigmentation. This difference stems from subtle structural variations that alter affinity distribution across receptor subtypes. Investigators propose that such selectivity produces a different side effect profile in specific applications. However, downstream consequences of prolonged receptor activation remain uncertain in the literature. Published studies do not fully agree on the duration of signaling pathway activity and the mechanisms of desensitization.
From a pharmacokinetic standpoint, the peptide is usually delivered by injection because oral bioavailability is very low; proteases in the digestive tract degrade it rapidly. After subcutaneous administration, plasma concentrations reach a peak within roughly one hour. Its elimination half-life is relatively short, with most reports placing it in the range of a few hours. Nasal formulations have also been examined, though absorption varies widely between individuals. Metabolism proceeds mainly through peptidase cleavage, and the resulting products are excreted by the kidneys.
Bremelanotide is a synthetic cyclic heptapeptide developed as an analogue of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation and appetite signalling. Its structure contains seven amino acid residues joined by a lactam bridge that closes the ring between two side chains. The molecular formula is C50H68N14O10 and the nominal molecular mass is near 1025 daltons. Much of the early laboratory literature refers to the same molecule by the development code PT-141.
The compound emerged from a research programme examining melanocortin analogues for effects on skin pigmentation. During early human studies, participants reported spontaneous erections as an unexpected side effect, which redirected development toward sexual function rather than tanning. An intranasal formulation was investigated in clinical trials but did not reach market approval. A subcutaneous injectable version later completed the regulatory process, and the nasal route does not appear in approved labelling.
| Property | Value | Notes |
|---|---|---|
| Primary target | Melanocortin receptors | Mainly the MC4R subtype |
| Route of administration | Injection | Typically subcutaneous |
| Time to peak | About 60 minutes | After subcutaneous dosing |
| Elimination half-life | Roughly 2 to 3 hours | Values vary across reports |
| Metabolic pathway | Peptidase hydrolysis | Cleared by the kidneys |
Melanocortin receptors form a family of five G-protein-coupled proteins, labelled MC1R through MC5R, that respond to peptides derived from pro-opiomelanocortin. Alpha-melanocyte-stimulating hormone and adrenocorticotropic hormone are the best-known endogenous ligands. The receptors are distributed differently across tissues, so a single agonist can produce effects in the brain, skin, adrenal gland and vasculature. This distribution explains why one peptide can influence both pigmentation and motivated behaviour.
Bremelanotide is a cyclic heptapeptide that binds several melanocortin receptors rather than one. In vitro assays report agonist activity at MC1R, MC3R, MC4R and MC5R, with MC4R generally treated as the subtype most relevant to sexual effects. MC4R is expressed in hypothalamic nuclei involved in appetite, energy balance and motivated behaviour, which provides a plausible route for central action. Selective MC4R agonists studied in animals produce comparable behavioural changes, supporting that interpretation.
How receptor activation translates into a change in desire is not established in detail. Proposed steps include modulation of dopaminergic signalling in reward circuits and downstream effects on autonomic tone. Human data consist mainly of clinical trials measuring self-reported outcomes rather than direct measurements of brain activity or transmitter release. The transient rise in blood pressure sometimes observed after administration is likewise reported consistently but explained only partly by known melanocortin pathways.
== Reactions == Ammonium sulfate decomposes upon heating above 250 °C (482 °F), first forming ammonium bisulfate. Heating at higher temperatures results in decomposition into ammonia, nitrogen, sulfur dioxide, and water. As a salt of a strong acid (H2SO4) and weak base (NH3), its solution is acidic; the pH of 0.1 M solution is 5.5. In aqueous solution the reactions are those of [NH4]+ and SO2−4 ions. For example, addition of barium chloride, precipitates out barium sulfate. The filtrate on evaporation yields ammonium chloride (NH4Cl). Ammonium sulfate forms many double salts (ammonium metal sulfates) when its solution is mixed with equimolar solutions of metal sulfates and the solution is slowly evaporated. With trivalent metal ions, alums such as ferric ammonium sulfate (NH4Fe(SO4)2·12H2O) are formed. Double metal sulfates include ammonium cobaltous sulfate, ferrous diammonium sulfate ((NH4)2SO4·Fe(SO4)·6H2O), ammonium nickel sulfate which are known as Tutton's salts (M2M′(SO4)2(H2O)6) and ammonium ceric sulfate ((NH4)4Ce(SO4)4·2H2O). Anhydrous double sulfates of ammonium also occur in the Langbeinites family. Airborne particles of evaporated ammonium sulfate comprise approximately 30% of fine particulate pollution worldwide. It reacts with additional sulfuric acid to give triammonium hydrogen disulphate, (NH4)3H(SO4)2.
This hypothesis posits that the physiological processes of mitochondrial stress induction (affecting neuronal plasticity) and vasodilation, which cooperatively increase microvascular blood flow and tissue oxygenation, are the basis of the natural neurostimulation. It is also thought to be a foundation of many non-invasive artificial neuromodulation techniques. Because if the mother-fetus interactions allow the child's nervous system to grow with adequate biological sentience, similar (while scaling) environmental interactions can heal the damaged nervous system in adults.
=== Advanced treatment plant technology === For some emerging contaminants, several advanced technologies—sonolysis, photocatalysis, Fenton-based oxidation and ozonation—have treated pollutants in laboratory experiments. Another technology is "enhanced coagulation" in which the treatment entity would work to optimize filtration by removing precursors to contamination through treatment. In the case of THMs, this meant lowering the pH, increasing the feed rate of coagulants, and encouraging domestic systems to operate with activated carbon filters and apparatuses that can perform reverse osmosis. Although these methods are effective, they are costly, and there have been many instances of treatment plants being resistant to pay for the removal of pollution, especially if it wasn't created in the water treatment process as many EC's occur from runoff, past pollution sources, and personal care products. It is also difficult to incentivize states to have their own policies surrounding contamination because it can be burdensome for states to pay for screening and prevention processes. There is also an element of environmental injustice, in that lower income communities with less purchasing and political power cannot buy their own system for filtration and are regularly exposed to harmful compounds in drinking water and food. However, recent treads for light-based systems shows great potential for such applications. With the decrease in cost of UV-LED systems and growing prevalence of solar powered systems, it shows great potential to remove CEC while keeping costs low.
Sources: en.wikipedia.org
=== Possible permanent effects === The adverse effects of isotretinoin may be permanent. This has been proposed to be due to induction of apoptosis (programmed cell death) in sebaceous glands, meibomian glands, neuroblastoma cells, hypothalamic cells, hippocampus cells, Dalton's lymphoma ascites cells, B16F-10 melanoma cells, neuronal crest cells, stem cells and others, that it changes epigenetics and shortens telomeres. Isotretinoin may stop long bone growth in young people who are still growing. Premature epiphyseal closure can occur in people receiving recommended doses of Accutane. Isotretinoin is known to cause meibomian gland dysfunction which causes persistent keratoconjunctivitis sicca (dry eye). Problems with the meibomian and salivary glands are likely due to the non-selective apoptosis of the cells of the exocrine glands. Decreased night vision has been reported to persist in some people after discontinuation of isotretinoin therapy, although most cases of decreased night vision appear to resolve after discontinuing the medication.
Human fat was mentioned in European pharmacopoeias since the 16th century as an important fatty component of quality deemed ointments and other pharmaceuticals in Europe. In old recipes human adipose tissue was mentioned as Pinguedo hominis, or Axungia hominis. The German medicinal Johann Agricola (1496–1570) described the recovery of human fat and its applications. In traditional medicine in Europe, human fat was believed to have a healing magic significance until the 19th century. Many executioners recovered the fat from the bodies of their executants, called "Armsünderfett" or "Armsünderschmalz" (German: fat or grease from poor sinners put to death), and sold it. For some executioners the marketing of human fat was a major source of revenue. The human fat was used to make ointments for treatment of various diseases such as bone pain, toothache and gout. It was also regarded as a panacea for particular diseases associated with cachexia (e.g. tuberculosis). Also an analgesic effect in rheumatoid arthritis was attributed to human fat. From the late 19th century, human fat was produced and offered under the trade name Humanol as a sterile, liquified preparation for injections in Germany. In 1909 it was introduced for surgical treatment of scars, wound disinfection, and wound revisions. In the 1920s it became out of fashion after low cure rates and the incidence of fat embolisms caused by its application.
An independent panel upholds the Parliamentary Commissioner for Standards' decision that Scott Benton, MP for Blackpool South, should face a 35-day suspension from Parliament. The suspension will now be voted on by MPs and could trigger another by-election. Heather Woodbridge, aged 29, is appointed as leader of Orkney Islands Council, becoming Scotland's youngest council leader and the first woman to lead Orkney Islands Council. 21 February – An Opposition day House of Commons debate calling for a ceasefire in Gaza descends into chaos after Speaker Sir Lindsay Hoyle breaks with Parliamentary convention to allow a vote on a Labour amendment calling for an "immediate humanitarian ceasefire" over the scheduled SNP motion calling for an "immediate ceasefire". The decision leads to protests from both Conservative and SNP MPs, who walk out of the House, leaving Labour's motion to be nodded through when the other two parties do not take part in the vote. Amid calls for his resignation, Hoyle says that he allowed the House to vote on the Labour motion so MPs could express their view on "the widest range of propositions", and to protect MPs' safety. King Charles III is seen back at work and meeting Prime Minister Rishi Sunak, the first time he has been seen back at work since his cancer diagnosis. Senior civil servant Sarah Munby writes to the Business Secretary to reject allegations by former Post Office chairman Henry Staunton that he was told to delay compensation payments to victims of the Horizon scandal.
Sources: en.wikipedia.org
It primarily activates specific subtypes in the melanocortin receptor family. These receptors are G protein-coupled and mediate signaling mainly within the central nervous system.
It activates pigmentation-related receptors more weakly. This selectivity is thought to alter its side effect profile.
Injection is the most common route. Nasal administration has been studied as well, though absorption varies considerably.
It is a synthetic cyclic peptide that acts as an agonist at melanocortin receptors. It is not a hormone replacement therapy and not a vasodilator in the usual clinical sense, although it does affect vascular tone. Chemically it belongs to the melanocortin analogue family.